Namenda (Memantine) for Non-motor Symptoms in Parkinson's Disease

NCT00646204 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Parkinson's Disease

Interventions

DRUG: Memantine
DRUG: placebo

Sponsor

Baylor College of Medicine

Collaborators

[object Object]